EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioinformatic Analysis of C1GALT1 in Cancer: Insights Into Prognosis, Metastasis and Therapeutic Potential

Ecem Kalemoglu iD, Ayse Caner iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Ecem Kalemoglu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rutgers-Jersey City Medical Center, Jersey City, New Jersey, USA. Hauptthemen laut MEDLINE: Galactosyltransferases, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluates the expression, regulation, and clinical relevance of C1GALT1, a key enzyme in mucin‐type O‐glycosylation, across a broad spectrum of human cancers. Aberrant glycosylation is a well‐established hallmark of malignancy, contributing to tumor growth, immune evasion, and metastasis. C1GALT1, also known as core 1 β1,3‐galactosyltransferase or T‐synthase, catalyzes the formation of the core 1 O‐glycan structure and requires the chaperone Cosmc for proper folding and activity. While previous studies have implicated C1GALT1 in cancer progression, a systematic pan‐cancer analysis exploring its gene expression patterns, epigenetic regulation, immune interactions, and prognostic significance has not been fully elucidated.

Aims

This study aims to computationally investigate C1GALT1 expression, regulation, and clinical relevance across multiple cancers using TCGA datasets to evaluate its potential as a biomarker and therapeutic target.

Methods

We conducted a comprehensive bioinformatic analysis of C1GALT1 using publicly available datasets from The Cancer Genome Atlas (TCGA). Gene expression, DNA methylation, and survival analyses were performed, along with correlation analyses between C1GALT1 and proliferation‐ or metastasis‐related genes, Cosmc expression, and immune cell infiltration (specifically, regulatory T‐cells [Tregs] and myeloid‐derived suppressor cells [MDSCs]), using transcriptomic web platforms.

Results

C1GALT1 expression was significantly upregulated in gastrointestinal and genitourinary cancers compared to normal tissues, while downregulated in thyroid, breast, and prostate cancers. Elevated expression correlated with reduced overall survival in lung, bladder, liver, and glioma/glioblastoma. DNA methylation analysis showed an inverse correlation between methylation and expression levels in multiple cancer types. C1GALT1 expression positively correlated with Cosmc, proliferation markers (MKI67, PCNA, MCM family, PLK1), and several metastasis‐associated genes. Immune profiling revealed context‐dependent correlations: C1GALT1 negatively correlated with Tregs and MDSCs in gastrointestinal cancers but positively in lung, breast, and prostate cancers.

Conclusion

Our pan‐cancer analysis suggests that C1GALT1 is differentially expressed and epigenetically regulated across tumor types and may contribute to tumor proliferation, metastasis, and immune modulation. While these findings support C1GALT1 as a potential biomarker and therapeutic target, further in vitro and in vivo studies are necessary to validate its mechanistic roles and clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalactosyltransferasesNeoplasmsBiomarkers, TumorHumansPrognosisComputational BiologyGene Expression Regulation, NeoplasticDNA MethylationNeoplasm MetastasisEpigenesis, GeneticMolecular Chaperones

Stichwörter der Autor:innen

C1GalT1T‐synthasecancerglycosylationtranscriptomicstumor‐infiltrating lymphocytes

Substanzen

GalactosyltransferasesC1GALT1 protein, humanBiomarkers, TumorC1GALT1C1 protein, humanMolecular Chaperones

Autor:innen und Institutionen

  • Department of Internal Medicine, Rutgers-Jersey City Medical Center, Jersey City, New Jersey, USA.
  • Department of Basic Oncology, Institute of Health Sciences, Ege University, Bornova, Izmir, Turkiye.
  • Translational Pulmonary Research Center (EGESAM), Ege University, Bornova, Izmir, Turkiye.
  • Department of Parasitology, Faculty of Medicine, Ege University, Bornova, Izmir, Turkiye.

ORCID-Profile: Ecem Kalemoglu, Ayse Caner

Zitieren

APA

Kalemoglu, E., & Caner, A. (2025). Bioinformatic Analysis of C1GALT1 in Cancer: Insights Into Prognosis, Metastasis and Therapeutic Potential. Cancer Reports. https://doi.org/10.1002/cnr2.70259

Vancouver

Kalemoglu E, Caner A. Bioinformatic Analysis of C1GALT1 in Cancer: Insights Into Prognosis, Metastasis and Therapeutic Potential. Cancer Reports. 2025. doi:10.1002/cnr2.70259

BibTeX
@article{Kalemoglu2025,
  author = {Kalemoglu, Ecem and Caner, Ayse},
  title = {Bioinformatic Analysis of C1GALT1 in Cancer: Insights Into Prognosis, Metastasis and Therapeutic Potential},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70259}
}
Kostenlos starten →